Physician profile
Reginald C Baptiste
NPI 1649202979
$5,174.71
in general payments reported to CMS, 2019-2025
12 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $1,407 · 2021: $211 · 2022: $459 · 2023: $345 · 2024: $1,103 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700 · Consulting Fee: $525 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.39 |
| Consulting Fee | $525.00 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,628.43 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $578.38 | 2024-2025 | Imfinzi |
| Medtronic, INC. | $483.70 | 2021-2025 | Corevalve Evolut R, Tri-Ad |
| Vascular Technology, INC. | $400.00 | 2024 | |
| Edwards Lifesciences Corporation | $376.69 | 2019-2024 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Biom'Up France Sas | $171.01 | 2020 | |
| Abbott Laboratories | $158.96 | 2022-2024 | Epic, Esprit |
| Abiomed | $143.93 | 2023 | Impella |
| Davol INC. | $113.11 | 2023 | Phasix Mesh |
| Penumbra, INC. | $65.96 | 2025 | Penumbra System |
| Conmed Corporation | $33.33 | 2022 | |
| Grifols USA, LLC | $21.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Baptiste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.